Asthma in Patients With Japanese Cedar Pollinosis

被引:0
|
作者
Tanaka, Akihiko [1 ]
Minoguchi, Kenji [2 ]
Pawankar, Ruby [3 ]
Adachi, Mitsuru [1 ]
机构
[1] Showa Univ, Div Allergy & Resp Med, Dept Internal Med, Tokyo, Japan
[2] Sumiregaoka Clin, Yokohama, Kanagawa, Japan
[3] Nippon Med Sch, Tokyo, Japan
来源
WORLD ALLERGY ORGANIZATION JOURNAL | 2012年 / 5卷
关键词
Japanese cedar pollinosis; asthma; allergic rhinitis;
D O I
暂无
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Japanese cedar pollen is the most common causative allergen for seasonal allergic rhinitis (AR) in Japan. More commonly known as Japanese cedar pollinosis, it occurs in spring causing the typical symptoms of seasonal AR, such as sneezing, rhinorrhea, nasal obstruction, nasal itching, and itching of the eyes. Previous reports indicate that the prevalence of Japanese cedar pollinosis among Japanese was 26.5%. According to a more recent questionnaire-based survey, the prevalence of Japanese cedar pollinosis in patients with adult asthma might be up to 30% to 50%, suggesting higher rates than that previously reported. Moreover, 30% to 60% of adult asthmatic patients with concomitant pollinosis have exacer-bations of their asthma symptoms during the Japanese cedar pollen season. These findings suggest that concomitant Japanese cedar pollinosis may be an aggravating factor in patients with asthma. As with other pollens, such as grass and birch, Japanese cedar pollen was shown to be a trigger factor for worsening asthma. In clinical practice, a number of Japanese patients with asthma are mono-sensitized to Japanese cedar pollen but not to other antigens. Further studies are needed to elucidate the mechanisms of Japanese cedar pollen in inducing and in exacerbating asthma. The presence of concomitant AR is often associated with the difficulty in asthma control. However, there has been a controversy whether treating concomitant AR by intranasal corticosteroid would produce better asthma-related outcomes in patients with asthma and AR. The effect of treating concomitant cedar pollinosis by intranasal corticosteroids on asthma control in patients with asthma and cedar pollinosis also remains unknown. Certain systemic treatments, such as leukotriene receptor antagonist and anti-IgE monoclonal antibody, are supposed to reduce the symptoms of both asthma and AR in patients with asthma and concomitant AR. In conclusion, Japanese cedar pollinosis is often associated with exacerbations of asthma. Further investigations are expected to elucidate the precise impact and mechanisms of Japanese cedar pollinosis in asthma.
引用
收藏
页数:5
相关论文
共 50 条
  • [21] Relationship between airborne pollen count and treatment outcome in Japanese cedar pollinosis patients
    Kenji Takasaki
    Kaori Enatsu
    Hidetaka Kumagami
    Haruo Takahashi
    European Archives of Oto-Rhino-Laryngology, 2009, 266 : 673 - 676
  • [22] Noninvasive biological evaluation of response to pranlukast treatment in pediatric patients with Japanese cedar pollinosis
    Gotoh, Minoru
    Okubo, Kimihiro
    Hashiguchi, Kazuhiro
    Wakabayashi, Ken-ichiro
    Kanzaki, Sho
    Tanaka, Nobuaki
    Fujioka, Masato
    Kawashima, Kayoko
    Suematsu, Kiyochika
    Sasaki, Koichi
    Iwasaki, Manabu
    Yamamotoya, Hajime
    ALLERGY AND ASTHMA PROCEEDINGS, 2012, 33 (06) : 459 - 466
  • [23] Effects of sublingual immunotherapy with tablets or drops containing Japanese cedar pollen antigens on nasal symptoms and sleep disturbance in patients with Japanese cedar pollinosis
    Fujii, Tatsuya
    Kitamura, Yoshiaki
    Kamimura, Seiichiro
    Takeda, Noriaki
    JOURNAL OF MEDICAL INVESTIGATION, 2022, 69 (1-2) : 97 - 100
  • [24] Analysis of T-helper responses and FOXP3 gene expression in patients with Japanese cedar pollinosis
    Chikamatsu, Kazuaki
    Sakakura, Koichi
    Matsuoka, Tomokazu
    Endo, Shuichiro
    Takahashi, Goro
    Matsuzaki, Zensei
    Masuyama, Keisuke
    AMERICAN JOURNAL OF RHINOLOGY, 2008, 22 (06): : 582 - 588
  • [25] Immune Regulation by CD4+CD25+Regulatory T Cells in Patients with Japanese Cedar Pollinosis
    Yamanishi, Takahiro
    Chikamatsu, Kazuaki
    Takahashi, Goro
    Endo, Shuichiro
    Masuyama, Keisuke
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2011, 156 (02) : 187 - 195
  • [26] Comparison of fluticasone furoate and fluticasone propionate for the treatment of Japanese cedar pollinosis
    Okubo, Kimihiro
    Nakashima, Mitsuyoshi
    Miyake, Noboru
    Komatsubara, Masaki
    Okuda, Minoru
    ALLERGY AND ASTHMA PROCEEDINGS, 2009, 30 (01) : 84 - 94
  • [27] Preliminary study of a challenge test to the patients with Japanese cedar pollinosis using an environmental exposure unit
    Ito, Kanako
    Terada, Tetsuya
    Yuki, Ayumi
    Ichihara, Takahiro
    Hyo, Sawako
    Kawata, Ryo
    Takenaka, Hiroshi
    Amano, Kentaro
    Ishiguro, Takeshi
    Ro, Toshitami
    AURIS NASUS LARYNX, 2010, 37 (06) : 694 - 699
  • [28] Predictors of adherence to sublingual immunotherapy for Japanese cedar pollinosis: a prospective analysis
    Kikkawa, Sayaka
    Kamijo, Atsushi
    Nakagome, Kazuyuki
    Soma, Tomoyuki
    Kobayashi, Takehito
    Uchida, Yoshitaka
    Kase, Yasuhiro
    Nagata, Makoto
    ASIAN PACIFIC JOURNAL OF ALLERGY AND IMMUNOLOGY, 2021, 39 (04) : 266 - 271
  • [29] Sublingual Immunotherapy for Japanese Cedar Pollinosis: Current Clinical and Research Status
    Sakurai, Daiju
    Ishii, Hiroki
    Shimamura, Ayumi
    Watanabe, Daisuke
    Yonaga, Takaaki
    Matsuoka, Tomokazu
    PATHOGENS, 2022, 11 (11):
  • [30] The impact of co-existing seasonal allergic rhinitis caused by Japanese Cedar Pollinosis (SAR-JCP) upon asthma control status
    Hojo, Masayuki
    Ohta, Ken
    Iikura, Motoyasu
    Hirashima, Junko
    Sugiyama, Haruhito
    Takahashi, Kazuhisa
    ALLERGOLOGY INTERNATIONAL, 2015, 64 (02) : 150 - 155